Hui Xu

1PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jul 31, 2024
A DXd/TLR7-Agonist Dual-Conjugate Anti-HER2 ADC Exerts Robust Antitumor Activity Through Tumor Cell Killing and Immune Activation.

Hangtian Yue, Hui Xu, Lanping Ma

Pageof 1

Frequent Collaborators

1 joint publications

Hangtian Yue

1 joint publications

Lanping Ma

1 joint publications

Xiyuan Li

1 joint publications

Biyu Yang